Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Acreage Announces Comprehensive Financing Transactions
-
Canaccord Genuity Downgrades Aurora Cannabis (ACB:CN) (ACB) to Hold
-
GrubHub Inc. (GRUB) PT Raised to $65 at Canaccord Genuity, Following Earnings
-
Hecla Mining (HL) PT Raised to $3 at Canaccord Genuity, Following Earnings
-
BCE Inc. (BCE:CN) (BCE) PT Raised to Cdn$69 at Canaccord Genuity, Following Earnings
-
Transaction in Own Shares
-
Chi-Med Announces the Exercise of Underwriters’ Over-allotment Option for Public Offering of ADSs
-
Chi-Med Announces the Exercise of Underwriters’ Over-allotment Option for Public Offering of ADSs
-
Chi-Med Announces the Exercise of Underwriters’ Over-allotment Option for Public Offering of ADSs
-
Canaccord Genuity Group Inc. Reports Third Quarter Fiscal 2020 Results
-
Tesla tumbles 17% as electrifying rally loses power
-
Canaccord Genuity Downgrades Tesla (TSLA) to Hold on Valuation
-
Canaccord Genuity Starts SeaSpine Holdings (SPNE) at Buy
-
TransGlobe Energy Corporation Announces Its 2020 Capital Budget and 2019 Year-End Reserves
-
TransGlobe Energy Corporation Announces Its 2020 Capital Budget and 2019 Year-End Reserves
-
ReconAfrica Announces Completion of Private Placement
-
ReconAfrica Announces Completion of Private Placement
-
Teladoc (TDOC) Receives NCQA Re-Certification - Canaccord Genuity
-
Result of AGM
-
Net Asset Value(s)
-
Black Diamond Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
-
Black Diamond Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
-
Black Diamond Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
-
Astronics (ATRO) PT Lowered to $28 at Canaccord Genuity, Following Earnings
-
Napco Security Technologies, Inc. (NSSC) PT Lowered to $29 at Canaccord Genuity, Wollowing Earnings
-
Total voting rights
-
IMAX Corporation (IMAX) PT Lowered to $23 at Canaccord Genuity
-
CMP 2020 Resource Limited Partnership Announces Filing of Final Prospectus
-
CMP 2020 Resource Limited Partnership Announces Filing of Final Prospectus
-
Black Diamond Therapeutics (BDTX) IPO Opens 74% Higher
-
Pre-Open Stock Movers 1/30: (MGEN) (TLSA) (NOW) Higher (SNDL) (BGG) (TSCO) Lower (more...)
-
Tesla shares hit record after blowout results, strong delivery forecast
-
UPDATE: Tesla (TSLA) PT Raised to $750 at Canaccord Genuity
-
UPDATE: Canaccord Genuity Starts Madrigal Pharmaceuticals (MDGL) at Buy
-
BERA Brand Management Closes Elite Partnerships to Accelerate Global Growth
-
Black Diamond Therapeutics (BDTX) Prices 10.586M Share IPO at $19/Sh
-
TransGlobe Energy Corporation Announces a Canadian Operations Update
-
Atalaya Mining PLC Announces Positive Legal Update on Proyecto Riotinto
-
Black Diamond Therapeutics Announces Pricing of Initial Public Offering
-
Black Diamond Therapeutics Announces Pricing of Initial Public Offering
-
MRF 2020 Resource Limited Partnership Closing February 26, 2020 – Maximum $50,000,000
-
Dynatrace Inc. (DT) PT Raised to $35 at Canaccord Genuity, Following Earnings Release
-
Green Dot (GDOT) on Watch on Chatter Square (SQ) Could Acquire the Company
-
Atalaya Mining PLC Announces Update on Proyecto Touro Permitting
-
Conatus Pharmaceuticals (CNAT) annouunces Histogen will merge with its wholly-owned subsidiary in an all-stock transaction
-
Conatus Pharmaceuticals and Histogen Enter into Definitive Merger Agreement
-
Erie Street Acquires Performance Improvement Partners
-
Net Asset Value(s)
-
Avivagen Announces Closing of Additional $1.75 Million Private Placement
-
UPDATE: Canaccord Genuity Upgrades Biogen (BIIB) to Buy Ahead of Adu Battle

